A new drug lowered blood pressure and improved kidney health markers in high-risk patients. Phase 3 trials will test its long-term effects. Preliminary research suggests that adding the new medication ...

Please provide your email address to receive an email when new articles are posted on . Overall, 90% of living donors had non-indexed and body surface area indexed mGFR measurements above recommended ...